Non-linear dynamics models characterizing long-term virological data from AIDS clinical trials.
暂无分享,去创建一个
[1] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[2] M A Nowak,et al. Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations. , 1997, Journal of theoretical biology.
[3] Marie Davidian,et al. The Nonlinear Mixed Effects Model with a Smooth Random Effects Density , 1993 .
[4] A S Perelson,et al. Mathematical analysis of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads. , 1998, Journal of theoretical biology.
[5] L B Sheiner,et al. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods. , 1984, Drug metabolism reviews.
[6] R. Anderson,et al. The dynamics of drug action on the within-host population growth of infectious agents: melding pharmacokinetics with pathogen population dynamics. , 1998, Journal of theoretical biology.
[7] H Wu,et al. Population HIV‐1 Dynamics In Vivo: Applicable Models and Inferential Tools for Virological Data from AIDS Clinical Trials , 1999, Biometrics.
[8] Claudio Cobelli,et al. Identifiability of compartmental systems and related structural properties , 1979 .
[9] J. Jacquez,et al. Numerical parameter identifiability and estimability: Integrating identifiability, estimability, and optimal sampling design , 1985 .
[10] M. Nowak,et al. Population Dynamics of Immune Responses to Persistent Viruses , 1996, Science.
[11] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[12] N M Ferguson,et al. Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] S D Kemp,et al. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. , 1995, Science.
[14] M. Nowak,et al. Competitive coexistence in antiviral immunity. , 2000, Journal of theoretical biology.
[15] W J Jusko,et al. Physiologic indirect response models characterize diverse types of pharmacodynamic effects , 1994, Clinical pharmacology and therapeutics.
[16] L M Wahl,et al. Adherence and drug resistance: predictions for therapy outcome , 2000, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[17] L B Sheiner,et al. Semiparametric models for antagonistic drug interactions. , 1994, Journal of applied physiology.
[18] A S Perelson,et al. Modeling plasma virus concentration during primary HIV infection. , 2000, Journal of theoretical biology.
[19] M A Nowak,et al. Coexistence and competition in HIV infections. , 1992, Journal of theoretical biology.
[20] V De Gruttola,et al. Estimation of HIV dynamic parameters. , 1998, Statistics in medicine.
[21] C. Cobelli,et al. Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. , 1980, The American journal of physiology.
[22] H. Akaike. A new look at the statistical model identification , 1974 .
[23] Paul Anderson,et al. The UNIX C shell field guide , 1986 .
[24] B. Efron,et al. Compliance as an Explanatory Variable in Clinical Trials , 1991 .
[25] J Urquhart,et al. Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens. , 1998, Statistics in medicine.
[26] J. Lisziewicz,et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.
[27] E. Hannan. Rational Transfer Function Approximation , 1987 .
[28] M A Nowak,et al. Human immunodeficiency virus drug therapy and virus load , 1997, Journal of virology.
[29] M A Nowak,et al. Mathematical biology of HIV infections: antigenic variation and diversity threshold. , 1991, Mathematical biosciences.
[30] Alan S. Perelson,et al. Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.
[31] A. J. Hall. Infectious diseases of humans: R. M. Anderson & R. M. May. Oxford etc.: Oxford University Press, 1991. viii + 757 pp. Price £50. ISBN 0-19-854599-1 , 1992 .
[32] Claudio Cobelli,et al. Global identifiability of nonlinear models of biological systems , 2001, IEEE Transactions on Biomedical Engineering.
[33] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.